Read all the latest news headline updates on biocon stock. Get all the biocon stock breaking news updates, videos, photostories and more at Business Standard.

Biocon's stock declines despite acquiring Biocon Biologics as a wholly-owned subsidiary, reflecting mixed investor sentiment.

Tech Mahindra, Axis Bank, Godrej Properties, RITES, SIS, Jagsonpal Pharma, and Sterling and Wilson Renewable Energy are top ...

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced that Siddharth Mittal has assumed the role of Managing Director and Chief ...

Biocon shares jump 8% post Q4 results. Is the Street happy? Biocon's shares surged by 8% on Tuesday due to strong Q4 earnings ...

Solid earnings, robust biosimilars growth, and improving margins drive renewed optimism; analysts see double-digit upside ...

Indian contract research, development and manufacturing organization Syngene International has appointed Siddharth Mittal as managing director and chief executive.

Watch Biocon and pharma stocks for a potential Nifty rebound as FIIs cover shorts—stay updated on key breakout levels!

Kiran Mazumdar-Shaw says the company is expanding capacity to meet growing demand while major drugmakers prioritise newer therapies ...

Biocon Biologics and Regeneron executed the settlement agreement to dismiss the pending appeal at the United States Court of Appeals for the Federal Circuit (USCAFC) of patent US11084865 ('865 patent) ...

Biocon's Malaysian partner Duopharma Biotech secures insulin supply contracts worth over MYR 225 million from Malaysia's ...

Viatris Inc. , the company formed by the merger of Mylan and Pfizer Inc. unit Upjohn in 2020, said Monday it has reached an agreement to combine its biosimilars portfolio with Biocon Biologics Ltd.